201 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
and acknowledge that the failure to perform under this Agreement will cause an actual, immediate and irreparable harm and injury and that the Parties … of the investigation, remediation, or monitoring of such Hazardous Substances; (iv) natural resource damages, property damages, personal or bodily injury
8-K
EX-2.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
, personal or bodily injury or wrongful death relating to the presence of or exposure to Hazardous Substances (including asbestos-containing materials
8-K
EX-2.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
and irreparable harm and injury and that the Parties would not have any adequate remedy at law in the event that any of the provisions of this Agreement … , property damages, personal or bodily injury or wrongful death relating to the presence of or exposure to Hazardous Substances (including asbestos
8-K
EX-99.1
77s4ao2xi yglrjk84
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-10.2
g71yfq6yn mkvdado3
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
er8 hn655
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.4
vp2cmfnebdk0 7h
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-99.1
mtl9d 6njo
3 Aug 20
Ligand Reports Second Quarter 2020 Financial Results
7:48am
8-K
EX-99.1
uk675 z2uok6
12 Mar 19
Regulation FD Disclosure
10:02am